Individualizing Medicine Through PharmacoGenomics — Are There Ethical Concerns, in

Details

Author(s):
Publish Date:
2000
Publication Title:
The Business Case for PharmacoGenomics
Publisher:
AdvanceTech Monitor
Place of Publication:
Woburn
Editor(s):
  • N.S. Rudolph
Format:
Book, Section 229-243 Pages
Citation(s):
  • Henry T. Greely, Individualizing Medicine Through PharmacoGenomics – Are There Ethical Concerns, in The Business Case for PharmacoGenomics, N.S. Rudolph ed., Woburn: AdvanceTech Monitor, 2000.